BIORESTORATIVE THERAPIES, INC. (BRTX) Free cash flow 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.9MFY2025 · since FY2016: -$5.2M → -$10.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.9M | -30.8% |
| FY2024 | -$8.3M | -26.3% |
| FY2023 | -$6.6M | -6.8% |
| FY2022 | -$6.2M | -83.8% |
| FY2021 | -$3.4M | — |
| FY2019 | -$7.0M | -35.9% |
| FY2018 | -$5.1M | -32.7% |
| FY2017 | -$3.9M | +25.7% |
| FY2016 | -$5.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Net marginBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →